Log In
BCIQ
Print this Print this
 

RVT-104

  Manage Alerts
Collapse Summary General Information
Company Axovant Sciences Ltd.
DescriptionCombination of glycopyrrolate -- a muscarinic receptor antagonist -- and high-dose rivastigmine -- an acetylcholinesterase (AChE) inhibitor
Molecular Target Muscarinic receptor ; Acetylcholinesterase (AChE)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat dementia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today